Assessment of the influence of body fat indices on antihypertensive drug responses

Duygun Altıntaş Aykan,Ahmet Çağrı Aykan,Enes Çelik,Bayram Öztürk
DOI: https://doi.org/10.1111/bcp.16265
2024-10-03
British Journal of Clinical Pharmacology
Abstract:Aims Less than 50% of patients treated for hypertension reach a target office systolic blood pressure (SBP). We aimed to evaluate the role of adiposity on antihypertensive drug responses in newly diagnosed hypertensive patients. Methods Estimated glomerular filtration rates, body mass index (BMI), skinfold thickness (SFT), body surface areas and waist circumferences of 150 hypertensive patients naïve to treatment were measured. Treatment protocols were started as combination of angiotensin converting enzyme inhibitor (ACE‐I) plus calcium channel blocker (CCB), angiotensin receptor blocker plus CCB or ACE‐I plus diuretic. Pre‐treatment and change in blood pressure (ΔBP) after 4 weeks treatment were determined. Multiple linear regression analysis was used to find independent predictors of Δblood pressure changes, and multivariable binary logistic regression analysis to find independent predictors of target SBP
pharmacology & pharmacy
What problem does this paper attempt to address?